Carpio, C.; Qasem, A.; Buño, A.; Borobia, A.M.; Arnalich, F.; Rey, V.; Lázaro, T.; Mariscal, P.; Laorden, D.; Salgueiro, G.;
et al. Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19. J. Clin. Med. 2023, 12, 6299.
https://doi.org/10.3390/jcm12196299
AMA Style
Carpio C, Qasem A, Buño A, Borobia AM, Arnalich F, Rey V, Lázaro T, Mariscal P, Laorden D, Salgueiro G,
et al. Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19. Journal of Clinical Medicine. 2023; 12(19):6299.
https://doi.org/10.3390/jcm12196299
Chicago/Turabian Style
Carpio, Carlos, Ana Qasem, Antonio Buño, Alberto M. Borobia, Francisco Arnalich, Vega Rey, Teresa Lázaro, Pablo Mariscal, Daniel Laorden, Giorgina Salgueiro,
and et al. 2023. "Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19" Journal of Clinical Medicine 12, no. 19: 6299.
https://doi.org/10.3390/jcm12196299
APA Style
Carpio, C., Qasem, A., Buño, A., Borobia, A. M., Arnalich, F., Rey, V., Lázaro, T., Mariscal, P., Laorden, D., Salgueiro, G., Moreno, A., Peiró, C., Lorenzo, Ó., Álvarez-Sala, R., on behalf of COVID@HULP Working Group, & on behalf of POSTCOVID@HULP Working Group.
(2023). Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19. Journal of Clinical Medicine, 12(19), 6299.
https://doi.org/10.3390/jcm12196299
